Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
This article is part of Med Tech Outlook's Innovation Insights series featuring expert contributions nominated by our subscribers and reviewed by our editorial team.
Dr. Orest Lastow, CTO and Founder , Iconovo
Vaccine accessibility depends not only on therapeutic efficacy but also on delivery technologies that can overcome storage, distribution and administration barriers. Dr. Orest Lastow’s perspective shows why inhaled dry-powder delivery deserves attention from medtech stakeholders seeking simpler, safer and more practical approaches to expanding access to essential medicines.

The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
